A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells

Ou Huang(Ruijin Hospital), Kunwei Shen(Shanghai Jiao Tong University)

Oncology Reports

June 12, 2014

10.3892/or.2014.3249

Cited by 6

Related Papers

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9

|Molecules|2013|109

Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling

|PLoS ONE|2013|50

Hippo/YAP Signaling Choreographs The Tumor Immune Microenvironment to Promote Triple Negative Breast Cancer Progression Via TAZ/IL-34 Axis

|Research Square|2021|6